News

September 24, 2020September 24, 2020

COPD More Prevalent Than Estimated, With Mortality Linked to Aspergillosis, Review Finds

News

Chronic obstructive pulmonary disease (COPD) is more prevalent than previously thought and associated with a mortality rate that is likely higher than earlier estimates, a review study has found. ... Read more

September 22, 2020September 22, 2020

Agreement Reached for Hemp Facility to Support Potential COPD Therapy RespRx

News

PAO Group and Puration have entered a new agreement that will allow PAO Group to build a proprietary hemp cultivar development facility on Puration’s branded site in Farmersville, Texas, ... Read more

September 17, 2020September 17, 2020

Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life

News

Nebulized ensifentrine (RPL554) — which works both to widen the airways and as an anti-inflammatory — showed a significant early effect on breathlessness in people with chronic obstructive pulmonary ... Read more

September 10, 2020September 10, 2020

SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show

News

Synairgen‘s anti-viral therapy SNG001 has a good safety profile in people with chronic obstructive pulmonary disease (COPD), Phase 2 trial data show. The data also indicate that SNG001 induces ... Read more

September 8, 2020September 8, 2020

AstraZeneca’s New Data Shows Breztri Aerosphere Better for All Seasons

News

Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) outperformed Bevespi Aerosphere (glycopyrronium/formoterol fumarate) in reducing the rate of moderate or severe exacerbations in people with chronic obstructive pulmonary disease (COPD) during all seasons ... Read more

September 3, 2020September 3, 2020

Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests

News

Regular, low-dose oral morphine led to significant health improvements in adults with advanced chronic obstructive pulmonary disease (COPD) who regularly experienced shortness of breath, according to results of a ... Read more

September 1, 2020September 1, 2020

COPD Study: Fortified Whey Protein Beverage Increases Muscle Strength

News

Men with moderate-to-severe chronic obstructive pulmonary disease (COPD) who drank a beverage composed of whey protein fortified with magnesium and vitamin C had lower levels of the inflammation-associated protein ... Read more

August 27, 2020August 27, 2020

Blood Test for IL-32 May Diagnose COPD, Measure Severity, Study Says

News

A blood test to measure levels of the immune signaling protein interleukin-32 (IL-32) may be a useful biomarker to diagnose and assess the severity of chronic obstructive pulmonary disease ... Read more

August 25, 2020August 25, 2020

New Potential Therapeutic Target – FFA4 Protein – Discovered for COPD

News

Evidence of a new potential therapeutic target — a protein called free fatty acid receptor 4 (FFA4) — in the treatment of inflammatory airway diseases such as asthma and ... Read more

August 20, 2020August 20, 2020

Phase 2 Trial Starts Testing Multiple Doses of Ensifentrine in Inhaler Formulation

News

Verona Pharma has started the second part of a Phase 2 trial evaluating its investigational therapy ensifentrine (RPL544) in patients in the U.K. with moderate to severe chronic obstructive ... Read more